All UniQure articles
-
Business
Gene therapy gathers pace
Sarah Houlton charts the evolution, challenges and opportunities of cell and gene therapy
-
Business
BMS invests in gene therapy
Bristol-Myers Squibb makes $100 million deal with biotech uniQure
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe